DNMT1 and cancer: Genistein, a notable inhibitor of DNMTs, has been shown to block epigenetic mechanisms promoting cancer progression in prostate and esophageal cancer models, affecting promoter methylation and DNMT activity (Fang et al. 2005; Ho et al. 2011).